B. Chen Zhu

B. Chen Zhu
Partner

Edinburgh Tower, 33/F

Hong Kong, China

chenzhu@mofo.com

852 25850735

INDUSTRIES + ISSUES

Anti-Bias Strategy + Defense

BAR ADMISSIONS

New York

EDUCATION

University of Virginia, B.A.

University of Pennsylvania Law School, J.D.

朱晨昊律师是美富亚洲制裁与出口管制业务组的负责人,同时领导本所在大中华区的政府和内部调查工作。朱律师在处理美国经济制裁、反腐败、反洗钱、证券与会计欺诈,以及相关的企业治理和公司合规事宜方面经验十分丰富。

朱律师经常在涉及外国资产控制办公室(OFAC)和其他美国监管机构的具争议性执法事务中,为中国、美国和欧洲金融机构就美国经济制裁和出口管制事宜提供法律意见。他还经常协助银行和公司制定切实可行、基于风险的制裁和出口管制合规计划。

在过去18年里,朱律师曾担任主理律师处理过众多由美国监管机构发起的,针对一些最大型生命科学、技术和金融服务公司的美国反腐败执法行动。他经常就公司调查和合规补救问题为公司董事会和高级管理层提供法律咨询服务。

朱律师的客户包括金融服务、生命科学、技术、消费品零售以及酒店业等多个行业的大型国有企业、跨国公司和高级管理层,其业务重点是大中华区、日本、韩国和东南亚地区。

朱律师广获知名法律排名机构认可,曾被评为2024—2025年《钱伯斯大中华区法律指南》 企业调查/反腐败(国际所)“新秀律师”、2019—2025年Lexology Index Investigations “未来领袖”、2022—2025年《法律500强》中国大陆/香港地区监管/合规和争议解决类诉讼业务推荐律师,以及2024—2025年《法律500强》中国大陆/香港地区生命科学和医疗保健业务推荐律师。

朱律师经常在与反腐败、经济制裁和白领执法相关的法律会议和客户研讨会上发表演讲。

在加入美富之前,朱律师在一家顶级美国律所的香港和纽约办事处任职。

朱律师的母语是英文和普通话。他是香港律师会的注册外国律师。

Experience

A major Asian state-owned enterprise’s U.S. investigation

Represented a major Asian state-owned enterprise in a multi-year investigation by U.S. regulators into alleged sanctions and anti-money laundering issues.

A major global bank’s subsidiary’s alleged violations

Represented a European subsidiary of a major global bank in connection with alleged economic sanctions violations.

A multinational pharmaceutical company’s FCPA-related investigations

Represented a multinational pharmaceutical company on multi-year investigations by U.S. and Chinese authorities into FCPA issues in the company’s China operations.

A major U.S. pharmaceutical and medical device manufacturer’s internal investigations

Represented a major U.S. pharmaceutical and medical device manufacturer in various internal investigations relating to employees’ alleged bribery, embezzlement, collusion with business partners and corporate governance issues across Asia Pacific.

A global investment bank’s Asia operations’ investigation and responses to regulators

Represented a global investment bank’s Asia operations in conducting an investigation related to anti-corruption and internal controls issues and coordinating responses to multiple regulators in the U.S., Europe and Asia.

A leading global telecommunications company’s DOJ and SEC investigation

Represented a leading global telecommunications company in a multi-year investigation by the U.S. Department of Justice and Securities and Exchange Committee into bribery, embezzlement and accounting fraud issues in China.

A leading U.S. technology company’s controls enhancements

Represented a leading U.S. technology company in controls enhancements for procurement transactions and distributor relationships in high risk markets.

A major F&B company’s Southeast Asia operations’ FCPA internal investigations

Represented a major food & beverage company’s Southeast Asia operations in conducting multiple FCPA internal investigations and advising on controls enhancements and employee discipline.

Multiple global financial institutions’ U.S. investigations

Represented multiple global financial institutions investigated by U.S. authorities in relation to their hiring practices in Asia.

A Vietnamese TMT company’s pre-acquisition anti-corruption DD

Represented a Vietnamese company in the Telecommunications, Media and Technology sector in developing anti-corruption policies and procedures in preparation for acquisition by U.S. private equity investors.

A Chinese energy company’s founder and chairman’s criminal prosecution

Represented the founder and chairman of a Chinese energy company in defending a criminal prosecution in U.S. District Court on charges of bribery and export law violations.

A trader’s DOJ and CFTC investigations

Represented a trader at a major European bank in investigations by the U.S. Department of Justice and the Commodity Futures Trading Commission into the bank’s alleged spoofing and other market manipulation activities.

Rankings

Ranked: China Corporate Investigations/Anti-Corruption (International Firms)

Chambers Greater China Region 2024-2026

Recommended: China: Life Sciences and Healthcare: Foreign Firms

Legal 500 Asia Pacific 2024-2025

Recommended: Hong Kong: Dispute Resolution: Litigation

Legal 500 Asia Pacific 2022-2026

Recommended: China: Dispute Resolution: Litigation: Foreign Firms

Legal 500 Asia Pacific 2022-2025

Recommended: China: Regulatory/Compliance: Foreign Firms

Legal 500 Asia Pacific 2022-2026

Recommended: Hong Kong Regulatory: white-collar, compliance and investigations

Legal 500 Asia Pacific 2022-2026

Listed as Future Leader

Who’s Who Legal Investigations 2019 - 2022